# Fluorouracil With or Without Mitomycin in Treating Patients With Peritoneal Cancer

> **NCT00006112** · PHASE2 · UNKNOWN · sponsor: **Gustave Roussy, Cancer Campus, Grand Paris**

## Conditions studied

- Carcinoma of the Appendix
- Colorectal Cancer
- Primary Peritoneal Cavity Cancer

## Interventions

- **DRUG:** chemotherapy
- **DRUG:** fluorouracil
- **DRUG:** leucovorin calcium
- **DRUG:** mitomycin C

## Key facts

- **NCT ID:** NCT00006112
- **Lead sponsor:** Gustave Roussy, Cancer Campus, Grand Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 1996-01
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2011-04-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00006112

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00006112, "Fluorouracil With or Without Mitomycin in Treating Patients With Peritoneal Cancer". Retrieved via AI Analytics 2026-07-11 from https://api.ai-analytics.org/clinical/NCT00006112. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*